| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1027302T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0127302 |
| P932 | PMC publication ID | 4468176 |
| P698 | PubMed publication ID | 26075717 |
| P5875 | ResearchGate publication ID | 280032989 |
| P2093 | author name string | Isao Date | |
| Jun Morimoto | |||
| Akihiko Kondo | |||
| Feifei Wang | |||
| Tatsuya Sasaki | |||
| Cesario V Borlongan | |||
| Masahiro Kameda | |||
| Takao Yasuhara | |||
| Takashi Agari | |||
| Aiko Shinko | |||
| Takaaki Wakamori | |||
| Atsuhiko Toyoshima | |||
| Susumu Sasada | |||
| Hayato Takeuchi | |||
| Mihoko Okazaki | |||
| P2860 | cites work | Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 |
| Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. | Q44569653 | ||
| Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. | Q44658984 | ||
| Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats | Q44979503 | ||
| Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke | Q45042816 | ||
| Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after traumatic brain injury | Q46802118 | ||
| Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats | Q47197553 | ||
| BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. | Q47226339 | ||
| One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke | Q48156405 | ||
| Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke | Q48188339 | ||
| Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats | Q48339506 | ||
| Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study | Q48545692 | ||
| Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation | Q48548383 | ||
| Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats | Q48721941 | ||
| Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats | Q48951431 | ||
| Intravenous autologous bone marrow mononuclear cells for ischemic stroke | Q49015926 | ||
| Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. | Q49087443 | ||
| Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy | Q26865517 | ||
| Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia | Q33322707 | ||
| Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha | Q33564990 | ||
| Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes | Q33771764 | ||
| Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke | Q34468850 | ||
| Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. | Q36251075 | ||
| Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. | Q36472907 | ||
| Intravascular cell replacement therapy for stroke | Q37110216 | ||
| Stem cell transplantation for neuroprotection in stroke. | Q37238494 | ||
| Mannitol enhances delivery of marrow stromal cells to the brain after experimental intracerebral hemorrhage | Q37265516 | ||
| Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. | Q38046199 | ||
| Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. | Q38468496 | ||
| Electrical stimulation of the cerebral cortex exerts antiapoptotic, angiogenic, and anti-inflammatory effects in ischemic stroke rats through phosphoinositide 3-kinase/Akt signaling pathway | Q39798227 | ||
| Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model | Q40007652 | ||
| Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia | Q40078558 | ||
| Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats | Q40602391 | ||
| Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. | Q41522029 | ||
| Neuroprotective effects of liraglutide for stroke model of rats | Q42704044 | ||
| Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. | Q43103917 | ||
| Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model | Q43249693 | ||
| SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. | Q50649521 | ||
| Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. | Q50656814 | ||
| Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke | Q62109410 | ||
| Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization | Q73836239 | ||
| Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption | Q80837184 | ||
| Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke | Q82980062 | ||
| Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke | Q87041085 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | e0127302 | |
| P577 | publication date | 2015-06-15 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms | |
| P478 | volume | 10 |
| Q90599623 | Activated Mesenchymal Stem Cells Induce Recovery Following Stroke Via Regulation of Inflammation and Oligodendrogenesis |
| Q47797257 | Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke. |
| Q45740164 | Cell Therapy for Parkinson's Disease |
| Q35737488 | Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats |
| Q92756924 | Early Transplantation of Human Cranial Bone-derived Mesenchymal Stem Cells Enhances Functional Recovery in Ischemic Stroke Model Rats |
| Q64118806 | Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion |
| Q26747560 | Extracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic Tools |
| Q47405412 | Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell |
| Q36024051 | Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model |
| Q42697924 | Intra-arterial transplantation of human bone marrow mesenchymal stem cells (hBMMSCs) improves behavioral deficits and alters gene expression in rodent stroke model |
| Q50419940 | Long-Term Potentiation Enhances Neuronal Differentiation in the Chronic Hypoperfusion Model of Rats |
| Q33887223 | Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke |
| Q47146569 | Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain. |
| Q38843840 | Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease |
| Q41429849 | Neural differentiation of human Wharton's jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke rats |
| Q46490500 | Real-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous system. |
| Q54120749 | Recombinant Osteopontin Improves Neurological Functional Recovery and Protects Against Apoptosis via PI3K/Akt/GSK-3β Pathway Following Intracerebral Hemorrhage. |
| Q51760255 | Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke. |
| Q89763856 | Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model |
| Q38773427 | Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered |
| Q38903653 | Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration |
| Q39457984 | Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms |
| Q38742380 | Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke |
| Q38708452 | Suppression of Basic Fibroblast Growth Factor Expression by Antisense Oligonucleotides Inhibits Neural Stem Cell Proliferation and Differentiation in Rat models With Focal Cerebral Infarction |
| Q88696073 | The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke |
| Q91894595 | Therapeutic Potential of Human Amniotic Epithelial Cells on Injuries and Disorders in the Central Nervous System |
| Q57296288 | Transplantation of a bone marrow mesenchymal stem cell line increases neuronal progenitor cell migration in a cerebral ischemia animal model |
Search more.